title: Are cyclooxygenase-2 inhibitors being taken only by those who need them?
authors.affiliation: Slone Epidemiology Center, Boston University, MA 02215, USA. dkaufman@slone.bu.edu
authors.forename: David W
authors.initials: DW
authors.lastname: Kaufman
authors.forename: Judith P
authors.initials: JP
authors.lastname: Kelly
authors.forename: Lynn
authors.initials: L
authors.lastname: Rosenberg
authors.forename: Theresa E
authors.initials: TE
authors.lastname: Anderson
authors.forename: Allen A
authors.initials: AA
authors.lastname: Mitchell
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000075202:Contraindications; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage*; D011307:Drug Prescriptions; D004363:Drug Utilization; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D019538:Health Care Surveys; D006801:Humans; D018579:Patient Selection; D018570:Risk Assessment
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors